137 related articles for article (PubMed ID: 30503067)
41. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
[TBL] [Abstract][Full Text] [Related]
42. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
Stern RS; Nichols KT; Väkevä LH
N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
[TBL] [Abstract][Full Text] [Related]
43. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
Takashima A; Matsunami E; Yamamoto K; Kitajima S; Mizuno N
Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):218-21. PubMed ID: 2091746
[TBL] [Abstract][Full Text] [Related]
44. [Non-melanoma skin cancer: incidence time trends analysis in Girona, Spain, 1994-2007].
Vilar-Coromina N; Miró-Queralt J; Cano-Bautista A; Vilardell-Gil L; Torres Babié P; Marcos-Gragera R
Med Clin (Barc); 2011 Jul; 137(4):145-51. PubMed ID: 21601891
[TBL] [Abstract][Full Text] [Related]
45. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis.
Hannuksela-Svahn A; Sigurgeirsson B; Pukkala E; Lindelöf B; Berne B; Hannuksela M; Poikolainen K; Karvonen J
Br J Dermatol; 1999 Sep; 141(3):497-501. PubMed ID: 10583054
[TBL] [Abstract][Full Text] [Related]
46. Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight.
Leiter U; Garbe C
Adv Exp Med Biol; 2008; 624():89-103. PubMed ID: 18348450
[TBL] [Abstract][Full Text] [Related]
47. Incidence of non-melanoma skin cancer in West Glamorgan, South Wales.
Roberts DL
Br J Dermatol; 1990 Mar; 122(3):399-403. PubMed ID: 2322501
[TBL] [Abstract][Full Text] [Related]
48. p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms.
Proby CM; du Peloux Menagé H; McGregor JM; Hobbs C; Norris PG; Smith N; Hawk JL; McKee PH
J Cutan Pathol; 1993 Oct; 20(5):435-41. PubMed ID: 8300928
[TBL] [Abstract][Full Text] [Related]
49. [Skin cancer incidence in Zacatecas].
Pinedo-Vega JL; Castañeda-López R; Dávila-Rangel JI; Mireles-García F; Ríos-Martínez C; López-Saucedo A
Rev Med Inst Mex Seguro Soc; 2014; 52(3):282-9. PubMed ID: 24878087
[TBL] [Abstract][Full Text] [Related]
50. PUVA photocarcinogenesis in Cheshire.
Cockayne SE; August PJ
Clin Exp Dermatol; 1997 Nov; 22(6):300-1. PubMed ID: 9604461
[No Abstract] [Full Text] [Related]
51. Psoriasis and susceptibility to nonmelanoma skin cancer.
Stern RS; Scotto J; Fears TR
J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):67-73. PubMed ID: 3980806
[TBL] [Abstract][Full Text] [Related]
52. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
53. Skin cancer associated with commonly prescribed drugs: tumor necrosis factor alpha inhibitors (TNF-αIs), angiotensin-receptor blockers (ARBs), phosphodiesterase type 5 inhibitors (PDE5Is) and statins -weighing the evidence.
Nardone B; Orrell KA; Vakharia PP; West DP
Expert Opin Drug Saf; 2018 Feb; 17(2):139-147. PubMed ID: 29103328
[TBL] [Abstract][Full Text] [Related]
54. The risk of melanoma in association with long-term exposure to PUVA.
Stern RS;
J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
[TBL] [Abstract][Full Text] [Related]
55. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study.
Nijsten TE; Stern RS
J Am Acad Dermatol; 2003 Oct; 49(4):644-50. PubMed ID: 14512910
[TBL] [Abstract][Full Text] [Related]
56. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
Gasparro FP
Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
[TBL] [Abstract][Full Text] [Related]
57. Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy.
Park HS; Lee YS; Chun DK
J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):578-80. PubMed ID: 12941100
[TBL] [Abstract][Full Text] [Related]
58. Do cancer registries play a role in determining the incidence of non-melanoma skin cancers?
Anselmo Lima C; Sampaio Lima M; Maria Da Silva A; Prado Nunes MA; Macedo Lima MM; Oliveira Santos M; Lyra D; Kleber Alves C
Eur J Dermatol; 2018 Apr; 28(2):169-176. PubMed ID: 29619990
[TBL] [Abstract][Full Text] [Related]
59. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years.
Christenson LJ; Borrowman TA; Vachon CM; Tollefson MM; Otley CC; Weaver AL; Roenigk RK
JAMA; 2005 Aug; 294(6):681-90. PubMed ID: 16091570
[TBL] [Abstract][Full Text] [Related]
60. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]